Health knowledge made personal
|
Seattle Genetics to Present ADCETRIS® and ASG-5ME Data at ASCO Annual Meeting
Wed May 16 18:08:00 EDT 2012
Seattle Genetics, Inc. today announced that data from two of its antibody-drug conjugate programs, ADCETRIS and ASG-5ME, will be presented at the American Society of Clinical Oncology 2012 Annual Meeting being held June 1-5, 2012 in Chicago, IL.
Read full article »
|
|
Seattle Genetics Announces Health Canada Accepts ADCETRIS® New Drug Submission for Review
Wed May 23 09:00:00 EDT 2012
BOTHELL, Wash.--(BUSINESSWIRE)-- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for ...
Read full article »
|
|
David L. Rimoin MD, PhD, Director of the Cedars-Sinai Medical Genetics Institute, 1936 - 2012
Tue May 29 09:33:12 EDT 2012
David L. Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute, a pioneer in research in skeletal disorders and abnormalities who played a pivotal role in developing mass screenings for Tay-Sachs and other heritable disorders, died early Sunday in Los Angeles. He was 75.
Read full article »
|
|
Population Genetics Gets Funding under International Leukemia Study
Tue May 29 10:48:23 EDT 2012
Full-text access for registered users only. Existing users login here . New to GenomeWeb? Register quickly here for free access. The Noonan lab is studying changes in developmental gene regulation during human evolution on multiple levels.
Read full article »
|
|
Eurangie Park's commitment to genetics
Sun May 27 18:42:04 EDT 2012
EURANGIE Park Murray Greys principal Malcolm Carson is pushing the boundaries of the breed through the outcross of genetics.
Read full article »
|
|
Cancer Genetics IPO Faces Facebook
Tue May 15 12:25:52 EDT 2012
Cancer Genetics is pursuing a strategy that differs from Facebook's IPO plan, expert says. A Rutherford, N.J.-based start-up developing tools to diagnose cancer is planning to launch an initial public offering this week under the long shadow of Facebook's long-awaited blockbuster IPO.
Read full article »
|
|
Viral Genetics’ P-IND Clears FDA To Commence Clinical Trials in Humans
Mon May 21 16:16:53 EDT 2012
SAN MARINO, Calif.--(BUSINESS WIRE)--Viral Genetics Clears FDA to Begin First Ovarian Cancer Study Test Site for Metabolic Disruption Technology (MDT) Combination Therapy
Read full article »
|
|
David L. Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute, dies at 75
Tue May 29 14:17:28 EDT 2012
David L. Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute, a pioneer in research in skeletal disorders and abnormalities who played a pivotal role in developing mass screenings for Tay-Sachs and other heritable disorders, died early Sunday in Los Angeles. He was 75.
Read full article »
|
|
Viral Genetics' P-IND Clears FDA Process To Begin Clinical Trials In Humans
Mon May 21 16:40:52 EDT 2012
Viral Genetics' P-IND Clears FDA Process To Begin Clinical Trials In Humans
Read full article »
|
|
Health Canada accepts Seattle Genetics’ ADCETRIS NDS for review
Thu May 24 01:02:56 EDT 2012
Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.
Read full article »
|
